AI Space

Licenses / Knowledge library

Health AI Developer Foundations terms

Understand Health AI Developer Foundations terms: permissions, conditions and limitations.

Standards learning collection

Why learn Health AI Developer Foundations terms?

Make informed reuse and redistribution decisions under Health AI Developer Foundations terms; this lesson is not legal advice.

The problem it solves

Explains the obligations that a license label alone can hide. Verify the exact version and upstream terms.

Where it came from

Do Health AI model terms by themselves establish clinical approval? (Health AI Developer Foundations terms) No. Where should permissions for a MedGemma model be checked? (Health AI Developer Foundations terms) Its linked Health AI terms and model documentation. Does access to a Health AI model replace professional validation? (Health AI Developer Foundations terms) No. Why inspect redistribution obligations for Health AI derivatives? (Health AI Developer Foundations terms) Custom terms can remain applicable downstream. What should a developer distinguish for a Health AI deployment? (Health AI Developer Foundations terms) License permission versus regulatory and clinical suitability.

Build your understanding

Work through these exercises in order. Try the task before opening a reference.

  1. Do Health AI model terms by themselves establish clinical approval? (Health AI Developer Foundations terms)
  2. Where should permissions for a MedGemma model be checked? (Health AI Developer Foundations terms)
  3. Does access to a Health AI model replace professional validation? (Health AI Developer Foundations terms)
  4. Why inspect redistribution obligations for Health AI derivatives? (Health AI Developer Foundations terms)
  5. What should a developer distinguish for a Health AI deployment? (Health AI Developer Foundations terms)

More ways to practice

Level 2

Apply the rules

Inspect a real distribution using Health AI Developer Foundations terms. Identify its license version, required notices, upstream dependencies and any unresolved permissions.

Documentation and sources

Catalog research notes

Connect the ideas

Explore next

MIT LicenseApache License 2.0Model licensing and upstream terms

Real World Example

Illustrative business scenario · AI-generated from linked documentation · Not a measured customer case study

Clinical Diagnostic Tool Compliance Framework

A health-tech startup developing a diagnostic support application for radiologists.

The business problem

The startup risks legal liability and regulatory non-compliance by failing to enforce usage restrictions and failing to obtain necessary Health Regulatory Authorizations when distributing their AI-enhanced diagnostic model.

How this topic solves it

By adopting the Health AI Developer Foundations (HAI-DEF) terms, the startup establishes a formal compliance pipeline that mandates the inclusion of specific use restrictions in all downstream agreements and ensures that any model derivative undergoes rigorous regulatory review before distribution.

  1. Integrate the HAI-DEF Terms of Use into the startup's end-user license agreement (EULA) for all downstream clinical partners.
  2. Implement a mandatory notification system that alerts third-party recipients that the model is subject to HAI-DEF restrictions.
  3. Conduct a regulatory assessment to determine if the specific diagnostic application requires Health Regulatory Authorization.
  4. Attach the required Notice text file to all non-hosted distributions of the model derivatives.
  5. Maintain a clear audit trail of all modifications to the base model to ensure compliance with attribution requirements.
HAI-DEF Compliance Flow · Process flow

This diagram illustrates the flow of responsibilities when distributing a model derivative.

Developer

Entity modifying HAI-DEF

Model Derivative

Modified AI model

Regulatory Authority

Overseeing body

Third-Party User

Recipient of model

  • Developer → creates → Model Derivative
  • Model Derivative → seeks authorization → Regulatory Authority
  • Developer → distributes with terms → Third-Party User

Expected business outcome

The startup achieves a transparent, legally defensible distribution model that mitigates the risk of being classified as an unauthorized medical device manufacturer.

Limitations and checks

A significant tradeoff is the potential for Google to remotely restrict usage if they reasonably believe the service violates the agreement, which could cause sudden service outages for clinical users. Developers must monitor their usage patterns against the Prohibited Use Policy to prevent such interruptions.

Sources

Generated 2026-10-18 with gemini-3.1-flash-lite. Your assessment includes two questions about this example.

Catalog source: technology-maxxing. This page reproduces the existing catalog’s learning material and source links.